DeCode Files For Ch. 11 With Plan To Sell Assets
The company filed its petition Monday in the U.S. Bankruptcy Court for the District of Delaware, along with a plan to sell its Icelandic subsidiary Islensk Erfdagreining and drug discovery and development programs to Saga.
IE conducts deCode's human genetics research; manages its population genetics resources; and...
To view the full article, register now.